Delivery Order SPE2DR25D2104-SPE2DR26F3QVG
- Not listed
- The Defense Logistics Agency awarded a $5,607.96 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for supply of Miebo 100% eye drop in 3ml quantities. This is a firm fixed-price contract with an ultimate completion date of December 12, 2025, and represents a child delivery order under AmerisourceBergen's broader contract vehicle with DLA. The contract carries no set-aside designation, indicating it was awarded through open competition. Performance will be conducted at...
- The Defense Logistics Agency awarded a $1,401.99 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3ml) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed price, competitively awarded contract utilizes no set-aside designation and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,655.19 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop medication in 3ML units. This firm fixed-price delivery order, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a $1,227.37 firm fixed price delivery order to AmerisourceBergen Drug Corp for Miebo 100% Eye Drop 3ML, a pharmaceutical product for ophthalmic use. The delivery order, awarded on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a child contract issued under a larger indefinite delivery vehicle. This non-competitive award was placed with performance at the contractor's Conshohocken, Pennsylvania facility, which serves as...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,748.98 on November 25, 2025, for the supply of Miebo 100% eye drops (3ml). The Defense Logistics Agency (DLA) issued this competitively awarded, firm fixed-price delivery order, which is scheduled for completion by November 26, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $10,275.54 on December 4, 2025, for the supply of Miebo 100% eye drops (3ml). This is a firm fixed price, competitively awarded contract with a completion date of December 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,261.74 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,919.81 to AmerisourceBergen Drug Corp for the supply of Miebo 100% eye drop in 3ml quantities. This firm fixed price delivery order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,897.98 for Miebo 100% eye drop (3mL) under a firm fixed price contract. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside delivery order represents a competitive award to the pharmaceutical distributor for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $5,859.32 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Miebo 100% eye drop in 3ML units. This firm fixed price delivery order, with an ultimate completion date of December 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract is non-competitive and will be performed at the vendor's corporate office location in Conshohocken,...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3QVGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,030.93 of Miebo 100% eye drops (3mL) on December 8, 2025, with completion scheduled for December 9, 2025. This non-competitive delivery order represents a firm fixed price transaction executed through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's comprehensive Pharmaceutical Prime Vendor Global Program contract with DLA (valued at $999,999,999.00 through December 2026), which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to Department of Defense healthcare systems and military personnel worldwide. AmerisourceBergen's status as a major pharmaceutical distributor and critical federal medical vendor is demonstrated through its extensive portfolio of DLA contracts covering brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This transaction exemplifies the company's role in supporting military healthcare logistics through competitively awarded supply agreements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 12/7/25 |